imipenem, anhydrous has been researched along with Gram-Negative Bacterial Infections in 146 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.68) | 18.7374 |
| 1990's | 30 (20.55) | 18.2507 |
| 2000's | 50 (34.25) | 29.6817 |
| 2010's | 57 (39.04) | 24.3611 |
| 2020's | 8 (5.48) | 2.80 |
| Authors | Studies |
|---|---|
| Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
| Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D | 1 |
| Brown, NP; Pillar, CM; Sahm, DF; Shah, D; Torres, MK | 1 |
| Amicosante, G; De Luca, F; Luzzaro, F; Migliavacca, R; Mugnaioli, C; Pagani, L; Perilli, M; Pini, B; Pollini, S; Rossolini, GM; Spalla, M; Toniolo, A | 1 |
| Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL | 1 |
| Fisher, DA; Hsu, LY; Koh, TH; Kwa, A; Tam, VH; Tan, TY | 1 |
| Appelbaum, PC; Credito, K; Kosowska-Shick, K | 1 |
| Eb, F; Guillon, H; Mammeri, H | 1 |
| Kollef, MH; Windham, S | 1 |
| König, E; Zollner-Schwetz, I | 1 |
| Liu, B; Tong, S | 1 |
| Claeys, KC; Rybak, JM; Smith, JR | 1 |
| Aggrey, A; Boucher, HW; Brown, ML; Butterton, JR; Du, J; Joeng, HK; Kaye, KS; Khan, I; Paschke, A; Tipping, RW; Young, K | 1 |
| Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A | 1 |
| Huang, C | 1 |
| Heo, YA | 1 |
| Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
| Antonelli, A; Barozzi, A; Coppi, M; Fontana, C; Gargiulo, R; Giani, T; Liotti, FM; Mauri, C; Mirandola, W; Principe, L; Rossolini, GM; Spanu, T | 1 |
| Akers, W; Brown, ML; Du, J; Kartsonis, NA; Lee, YC; Mariyanovski, V; McLeroth, P; Paschke, A; Pedley, A; Sims, M | 1 |
| Kim, SY; Ko, KS; Rhee, JY; Shin, SY | 1 |
| Anandan, S; Devanga Ragupathi, NK; Gopi, R; Gunasekaran, P; Muthuirulandi Sethuvel, DP; Veeraraghavan, B; Walia, K | 1 |
| Bo, H; Hui-Min, Y; Lin Liu, Y; Shamsi, BH; Xu-Chun, M; Yan-Ping, W | 1 |
| Advincula, MR; McLaughlin, MM; Miglis, C; Scheetz, MH; Skoglund, E; Wagner, J | 1 |
| Kim, YA; Park, YS | 1 |
| Bhagunde, PR; Carr, DM; Harradine, P; Katwaru, R; Motyl, M; Racine, F; Rizk, ML; Si, Q; Wismer, MK; Wu, J; Xiao, JC; Young, K | 1 |
| Ahmed, MO; Álvarez, R; Daw, MA; Elramalli, AK; Kieffer, N; Nordmann, P; Poirel, L | 1 |
| Hawser, SP; Karlowsky, JA; Kazmierczak, KM; Lob, SH; Magnet, S; Motyl, MR; Sahm, DF; Young, K | 1 |
| Hoban, DJ; Lob, SH; Motyl, MR; Sahm, DF; Young, K | 1 |
| Gong, S; Hu, X; Jiang, Y; Li, J; Shang, X; Yu, R; Zhang, X; Zhang, Y | 1 |
| Gong, N; Jiang, J; Yang, L; Zhou, H | 1 |
| Attwood, M; Bowker, KE; MacGowan, AP; Noel, AR | 1 |
| Azougagh, K; Barbier, F; Boulain, T; Boutrot, M; Guinard, J | 1 |
| Choi, M; Karp, NS; Levine, SM; Weichman, KE; Wilson, SC | 1 |
| Bartolini, A; Biasolo, MA; Cavallaro, A; Frasson, I; Palù, G; Richter, SN | 1 |
| Bourdier, A; Haouy, S; Marchandin, H; Michon, AL; Saumet, L; Sirvent, N | 1 |
| Calcaño, C; Fuenmayor, Z; Montaño, C; Piñerúa Gonsálvez, JF; Rodney, H; Rodney, M; Zambrano Infantinot, Rdel C | 1 |
| Aduroja, OA; Afshartous, D; Amde, M; Bauer, SR; Connor, MJ; Fissell, WH; Groszek, JJ; Salem, C | 1 |
| Chlebicki, MP; Kwa, AL; Lee, AL; Lee, W; Liew, LT; Lim, CL; Nah, SC; Wan, CN | 1 |
| Chen, CS; Chen, PL; Ko, WC; Tang, HJ; Tsai, PJ; Wu, CJ | 1 |
| Arakawa, Y; Hattori, T; Kawamura, K | 1 |
| Cirioni, O; Ghiselli, R; Giacometti, A; Guerrieri, M; Kamysz, E; Kamysz, W; Mazzocato, S; Offidani, A; Orlando, F; Provinciali, M; Silvestri, C; Simonetti, O | 1 |
| Ogbolu, DO; Webber, MA | 1 |
| Ageevets, VA; Partina, IV; Sidorenko, SV | 1 |
| Hodsdon, ME; Kulkarni, MV; Murray, TS; Peaper, DR; Pyka, JS; Zurita, AN | 1 |
| Cheng, C; Rui, Y; Sun, J; Zheng, F | 1 |
| Armand-Lefevre, L; Burdet, C; Couffignal, C; Da Silva, D; Foucrier, A; Laouénan, C; Lasocki, S; Massias, L; Mentec, H; Mentré, F; Pajot, O; Wolff, M | 1 |
| Albornoz, E; Ceriana, P; Corso, A; Gomez, S; Lucero, C; Pasteran, F; Rapoport, M; Veliz, O | 1 |
| Badal, RE; Hackel, MA; Lob, SH; Sahm, DF | 1 |
| Al-Masaudi, S; Elawady, S; Elsherif, R; Harakeh, S; Ismail, D; Jastaniah, S; Karrouf, G | 1 |
| Das, T; Dave, VP; Jalali, S; Mathai, A; Narayanan, R; Nishant, K; Pappuru, RR; Pathengay, A; Sharma, P; Sharma, S | 1 |
| Barba, MJ; Bou, G; Kostrzewa, M; Oviaño, M; Sparbier, K | 1 |
| Ahmad, I; Akhtar, T; Ambreen, A; Gandapor, AJ; Khan, A; Khan, AM; Ullah, O | 1 |
| Fang, X; Guo, J; Jin, Y; Liu, C; Pan, F; Qin, L; Yan, W | 1 |
| Bhaskar, H; Chaudhary, U; Sharma, M | 1 |
| Goff, DA; Mangino, JE | 1 |
| Chen, YH; Hsu, HJ; Lee, MF; Peng, CF | 1 |
| Aldea, MJ; Alperí, A; Aspiroz, C; Figueras, MJ; Marco, F; Sánchez-Céspedes, J; Toledo, M; Vila, J | 1 |
| Heard, M; Lautenbach, E; Marsicano, R; Serrano, S; Stieritz, DD; Tolomeo, P | 1 |
| Cizmeci, Z; Dereli, N; Günay, E; Küçükbayrak, A; Uğurman, F | 1 |
| Aydemir, ZA; Celik, N; Celkan, T; Ozdemir, N | 1 |
| Girlich, D; Kolb, A; Naas, T; Nordmann, P | 1 |
| Aydemir, S; Bacakoğlu, F; Taşbakan, MS; Yamazhan, T | 1 |
| Memmi, M; Messadi, AA; Thabet, L; Turki, A | 1 |
| Chong, Y; Docquier, JD; Jeong, SH; Kim, CK; Lee, K; Seo, YH; Yong, D; Yum, JH | 1 |
| Cassettari, M; Chongthaleong, A; Christiansen, KJ; Cooper, D; Flamm, R; Garcia, J; Hsu, L; Ip, M; Ker, HB; Kiratisin, P; Mendoza, M; Morrissey, I; Okolo, P; Quintana, A; Redjeki, IS | 1 |
| Arias Rodríguez, M; Palomar Fontanet, R; Quintela Obregón, E; Rodrigo Calabia, E; Salas, C | 1 |
| Ko, KS; Lee, H; Peck, KR; Song, JH | 1 |
| Gomersall, C; Kuti, JL; Kwa, A; Montakantikul, P; Nicolau, DP; Roberts, JA | 1 |
| Flamm, RK; Korten, V; Laeuffer, JM; Morrissey, I; Mutters, R; Nordmann, P; Picazo, JJ; Quintana, A; Seak, JC | 1 |
| Apisarnthanarak, A; Apisarnthanarak, P; Kiratisin, P; Mundy, LM | 1 |
| Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN | 1 |
| Dong, M; He, J; Meng, X; Sun, M; Wang, DI; Yang, C; Zhu, L | 1 |
| Badal, RE; Boffard, KD; Botha, RF; Brink, AJ; Feldman, C; Grolman, DC; Joubert, I; Poswa, X; Pretorius, J; Richards, GA; Senekal, M; Veller, M | 1 |
| Ahmed, D; Cravioto, A; Endtz, HP; Hays, JP; Hoque, A; Huq, M; Islam, MA; Nabi, A; Pietroni, MA; Talukdar, PK; Talukder, KA | 1 |
| Han, L; He, X; Huang, L; Li, X; Liu, D; Liu, F; Liu, W; Shao, C; Wang, J; Wang, S; Wang, X; Wang, Y; Wei, X; Yang, Z; Yin, Z; Yuan, J; Zhu, L; Zou, D | 1 |
| Keel, RA; Kiratisin, P; Nicolau, DP | 1 |
| Blake, P; Brichacek, M; Kao, R | 1 |
| Andremont, A; Angebault, C; Armand-Lefèvre, L; Barbier, F; Bronchard, R; Defrance, G; El Mniai, A; Hamelet, E; Lepeule, R; Lucet, JC; Montravers, P; Plésiat, P; Ruppé, E; Wolff, M | 1 |
| Alvarez, M; Arribas, JM; Asensi, JM; Asensi, V; Carton, JA; Lago, M; Maradona, JA | 1 |
| Flores, C; Goldani, LZ; Hadlich, E; Maguilnik, I | 1 |
| Blanco, G; de Mier, C; Famiglietti, A; Juárez, J; Pugliese, L; Rodríguez, CH; Vay, C | 1 |
| Belzberg, H; Cornwell, EE; Gill, MA; Murray, JA; Salim, A; Sava, J; Velmahos, GC; Zhu, J | 1 |
| Doline, C; Kobrin, S; Lipschutz, JH; Nachamkin, I; Ruhe, J; Snyder, RW; Wasserstein, A | 1 |
| Cao, WF; Peng, YZ; Wang, HM; Xiao, GX; Yang, XY | 1 |
| Chong, Y; Kim, EC; Kim, MY; Kim, YA; Lee, HS; Lee, K; Park, YJ; Yong, D | 1 |
| Chiodo, F; Frank, G; Manfredi, R; Sabbatani, S | 1 |
| Ikeya, M; Ryo, E; Sugimoto, M | 1 |
| Akinci, E; Balaban, N; Bodur, H; Colpan, A; Erbay, A | 1 |
| Castagnola, E; Caviglia, I; Giona, F; Girmenia, C; Haupt, R; Micozzi, A; Parodi, S; Testi, AM | 1 |
| Han, K; Hong, SB; Kim, J; Lee, J; Shin, HS; Shin, KS; Son, BR; Youn, SJ | 1 |
| Ballerini, V; Limansky, AS; Marchiaro, P; Mussi, MA; Pasteran, F; Viale, AM; Vila, AJ | 1 |
| Bergholm, AM; Dornbusch, K | 1 |
| Chong, Y; Ha, GY; Jeong, SH; Lee, K; Lim, HS; Park, KH; Shin, JH; Yong, D | 1 |
| Choe, KW; Kang, CI; Kim, DM; Kim, EC; Kim, HB; Kim, NJ; Lee, CS; Oh, MD | 1 |
| Luczak, M; Marchel, H; Rudnicka, J; Wroblewska, MM | 1 |
| Chien, CC; Kuo, CY; Liu, JW; Tsai, MS; Wang, MC; Wu, HC | 1 |
| Francis, AL; How, SH; Tee, HP | 1 |
| Barra, D; Bozzi, A; Cirioni, O; Di Giulio, A; Ghiselli, R; Giacometti, A; Luzi, C; Mangoni, ML; Mocchegiani, F; Orlando, F; Rinaldi, AC; Saba, V; Scalise, G; Silvestri, C | 1 |
| Goldstein, EJ; Rodloff, AC; Torres, A | 1 |
| Bernander, S; Ericson, E; Fraenkel, CJ; Larsson, P; Melhus, A; Rydberg, J; Törnqvist, E; Ullberg, M | 1 |
| Archontoulis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Mega, A; Pavleas, I; Rigas, K; Thomopoulos, G; Vernikos, P | 1 |
| Alp, E; Aygen, B; Metan, G; Sumerkan, B | 1 |
| Bonnaure-Mallet, M; Jolivet-Gougeon, A; Sixou, JL; Tamanai-Shacoori, Z | 1 |
| Bennett, KM; Dodds-Ashley, E; Hayward, TZ; Kaye, KS; Scarborough, JE; Sharpe, M; Vaslef, SN | 1 |
| Guevara, A; Guevara, E; Guevara, M; Medina, L; Oliveros, M; Salomón, M | 1 |
| Deptuła, A; Gierlotka, K; Gospodarek, E; Michalska, A | 1 |
| Shah, PM | 1 |
| Bucklin, SE; Morrison, DC | 1 |
| Kuijper, EJ; Prins, JM; Speelman, P; van Agtmael, MA; van Deventer, SJ | 1 |
| Haig, GM; Pryka, RD | 1 |
| Jones, RN; Marshall, SA | 1 |
| Chandy, M; Ebenezer, S; Jesudason, MV; Lalitha, MK | 1 |
| Collins, L; Eliopoulos, GM; Malanoski, GJ; Moellering, RC; Wennersten, C | 1 |
| Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R | 1 |
| Eppes, SC; Klein, JD | 1 |
| Bell-Dixon, C; Itokazu, GS; Kahan, FM; Quinn, JP; Weinstein, RA | 1 |
| Blahová, J; Králiková, K; Krcméry, V; Kubonová, K | 1 |
| Ardanuy, C; Carratalá, J; Fernández-Sevilla, A; González-Barca, E; Grañena, A; Sanchez, A | 1 |
| Cetron, MS; Crane, GL; Finelli, L; Jarvis, WR; Paul, SM; Tokars, JI | 1 |
| Casali, A; Della Giulia, M; Di Lauro, L; Gionfra, T; Santini, S; Sega, FM; Vici, P | 1 |
| Klastersky, J | 1 |
| Ahmed, A; Ahmed, QT; Hafiz, S; Majeed, H; Syed, S | 1 |
| Arbo, MD; Barefoot, L; Hariharan, R; Nathan, C; Snydman, DR; Weinstein, RA | 1 |
| Aoun, M; Autier, P; Crokaert, F; Klastersky, J; Paesmans, M | 1 |
| Caldwell, JW; Johnson, RH; Singh, S | 1 |
| Ido, A; Inoue, S; Inoue, T; Itoh, H; Kataoka, H; Koono, M; Kuwata, G; Ogata, K; Takasaki, M; Tateyama, S; Tsubouchi, H; Yamashita, K | 1 |
| Makandiramba, B; Moyo, SR; Nziramasanga, P; Obi, CL; Robertson, V; Tswana, SA | 1 |
| Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M | 1 |
| Zafar, A | 1 |
| Matsubayashi, K; Morioka, K; Nomoto, T; Ogino, H; Sakakibara, Y; Sugita, T; Ueda, Y | 1 |
| Xiao, Z | 1 |
| Burgos, A; Campillos, P; Gonzalo, N; López-Lozano, JM; Monnet, DL; Saez, M; Yagüe, A | 1 |
| Chambers, H; Horn, D; Lemke, J; Luchi, M; Morrison, DC; Opal, S; Ryan, JL; Slotman, G; Wiesenfeld, H; Yoneda, K | 1 |
| Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
| Dascal, A; Miller, MA; Zaharatos, GJ | 1 |
| Carmeli, Y; Harbarth, S; Harris, AD; Samore, MH | 1 |
| Jankovic, V; Kalenic, S; Tambic Andrasevic, A; Tambic, T | 1 |
| Byl, B; Clevenbergh, P; Jacobs, F; Kentos, A; Marchant, A; Thys, JP; Vincent, JL | 1 |
| Ağca, B; Kalyoncu, A; Mihmanli, A; Sahin, I; Sakiz, D; Tahaoğlu, K; Tuncer, F | 1 |
| Badolati, A; Fontán, PA; Gammella, D; Maskin, B; Spinedi, EG | 1 |
| Benedetto, G; Enrichens, F; Franchello, A; Mao, P; Olivero, G; Olivero, S; Sciascia, C | 1 |
| De Rose, V; Pozzi, E | 1 |
| Dolna, I; Ruczkowska, J | 1 |
| Cruz, C; del Busto, R; Faber, MD; Mezger, E | 1 |
| Sesin, GP | 1 |
| Bruckner, DA; Champlin, RE; Ho, WG; Winston, DJ | 1 |
15 review(s) available for imipenem, anhydrous and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections?
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem | 2022 |
Treatment options for multidrug-resistant Gram-negatives in urinary tract infections.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Gram-Negative Bacterial Infections; Humans; Imipenem; Urinary Tract Infections | 2023 |
Imipenem-Cilastatin-Relebactam: A Novel β-Lactam-β-Lactamase Inhibitor Combination for the Treatment of Multidrug-Resistant Gram-Negative Infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cilastatin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests | 2020 |
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines | 2020 |
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Cilastatin; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Imipenem; Injections, Intravenous | 2021 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
Epidemiology and treatment of antimicrobialresistant gram-negative bacteria in Korea.
Topics: Acinetobacter baumannii; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Republic of Korea; Retrospective Studies | 2018 |
[Imipenem: 30-year experience in therapy].
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Drug Administration Schedule; Drug Combinations; Escherichia coli; Gene Expression; Gram-Negative Bacterial Infections; Humans; Imipenem; Pseudomonas aeruginosa | 2013 |
Capnocytophaga spp. brain abscess in an immunocompetent host: problems in antimicrobial chemotherapy and literature review.
Topics: Adult; Amikacin; Animals; Anti-Bacterial Agents; Bites and Stings; Brain Abscess; Capnocytophaga; Cats; Clindamycin; Diagnosis, Differential; Fluconazole; Gram-Negative Bacterial Infections; Humans; Imipenem; Male | 2004 |
Two decades of imipenem therapy.
Topics: Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem | 2006 |
Antimicrobial treatment of Capnocytophaga infections.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Capnocytophaga; Cilastatin; Clindamycin; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Microbial Sensitivity Tests | 2007 |
Parenteral carbapenems.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Parenteral; Meropenem; Thienamycins | 2008 |
Meropenem: a new carbapenem antimicrobial.
Topics: Clinical Trials as Topic; Drug Resistance, Microbial; Drugs, Investigational; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Renal Insufficiency; Thienamycins | 1994 |
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Neutropenia; Sepsis; Thienamycins | 1997 |
Imipenem in acute lung infections and bacterial re-exacerbations of chronic obstructive lung disease.
Topics: Acute Disease; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Thienamycins | 1991 |
15 trial(s) available for imipenem, anhydrous and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Cilastatin, Imipenem Drug Combination; Colistin; Drug Resistance, Multiple, Bacterial; Endpoint Determination; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Kidney; Male; Microbial Sensitivity Tests; Middle Aged; Sex Factors; Treatment Outcome; Young Adult | 2020 |
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Pyelonephritis; Urinary Tract Infections; Young Adult | 2017 |
[Changes in plasma levels of LPS, TNFalpha and IL-6 in burn patients with severe infection treated with Imipenem or Cefoperazone].
Topics: Burns; Cefoperazone; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Tumor Necrosis Factor-alpha | 2004 |
Clinical study of the effectiveness of imipenem/cilastatin sodium as the antibiotics of first choice in the expectant management of patients with preterm premature rupture of membranes.
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Third | 2005 |
Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxemia; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sepsis | 2006 |
Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Ceftazidime; Double-Blind Method; Endotoxins; Enterobacter cloacae; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Interleukin-8; Klebsiella pneumoniae; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Tumor Necrosis Factor-alpha; Urinary Tract Infections | 1995 |
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoplasma Infections; Neoplasms; Neutropenia; Pefloxacin; Thienamycins; Vancomycin | 1997 |
Imipenem versus targeted therapy in cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoses; Neoplasms; Neutropenia; Thienamycins | 1998 |
Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Health Care Costs; Humans; Imipenem; Male; Patient Admission; Pneumonia, Bacterial; Prospective Studies; Retrospective Studies; Thienamycins | 1999 |
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Middle Aged; Ofloxacin; Protease Inhibitors; Sepsis; Thienamycins | 1999 |
A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with gram-negative urosepsis. Urosepsis Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cytokines; Double-Blind Method; Endotoxins; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Sepsis; Urinary Tract Infections | 2000 |
Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections.
Topics: Bacteremia; Ceftazidime; Drug Administration Schedule; Endotoxins; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Injections, Intravenous; Interleukin-6; Male; Probability; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Tumor Necrosis Factor-alpha | 2001 |
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Statistics, Nonparametric; Thienamycins; Tumor Necrosis Factor-alpha | 2002 |
Imipenem-cilastatin in the treatment of hospital infections.
Topics: Cilastatin; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Imipenem; Prognosis; Protease Inhibitors; Thienamycins; Treatment Outcome | 1991 |
Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Ceftazidime; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Superinfection | 1991 |
116 other study(ies) available for imipenem, anhydrous and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA | 2008 |
In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; United States | 2008 |
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; Data Collection; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Integrons; Italy; Molecular Epidemiology; Molecular Sequence Data | 2008 |
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand | 2009 |
Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Utilization; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Public; Humans; Incidence; Microbial Sensitivity Tests; Singapore | 2010 |
Mutant prevention concentrations of four carbapenems against gram-negative rods.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutation; Phenotype; Pseudomonas aeruginosa; Thienamycins | 2010 |
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis | 2010 |
An investigation of Stenotrophomonas maltophilia-positive culture caused by fiberoptic bronchoscope contamination.
Topics: Anti-Bacterial Agents; Bronchoscopes; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Stenotrophomonas maltophilia | 2019 |
Extensively drug-resistant Alcaligenes faecalis infection.
Topics: Adult; Aged; Aged, 80 and over; Alcaligenes faecalis; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2020 |
Multicenter evaluation of the RAPIDEC® CARBA NP test for rapid screening of carbapenemase-producing Enterobacteriaceae and Gram-negative nonfermenters from clinical specimens.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Colorimetry; Gram-Negative Bacterial Infections; Hospitals; Humans; Hydrolysis; Imipenem; Italy; Mass Screening; Predictive Value of Tests; Prospective Studies; Pseudomonas aeruginosa; Sensitivity and Specificity; Time Factors | 2017 |
Imipenem-resistant Gram-negative bacterial isolates carried by persons upon medical examination in Korea.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carrier State; Cluster Analysis; DNA, Ribosomal; Feces; Genotype; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; Korea; Mass Screening; Microbial Sensitivity Tests; Molecular Typing; Phylogeny; Prevalence; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2017 |
First report of bla
Topics: Adult; Aeromonas caviae; beta-Lactamases; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Whole Genome Sequencing; Young Adult | 2017 |
Analysis of distribution and antibiotic resistance of pathogens isolated from the paediatric population in Shenmu Hospital from 2011-2015.
Topics: Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fungi; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Infant; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Mycoses; Penicillins; Retrospective Studies; Thienamycins; Vancomycin | 2018 |
Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infections.
Topics: Aged; Bacteremia; Cilastatin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2018 |
Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model.
Topics: Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Imipenem; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests | 2018 |
Colistin-resistant carbapenemase-producing isolates among Klebsiella spp. and Acinetobacter baumannii in Tripoli, Libya.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Health Facilities; Humans; Imipenem; Klebsiella; Libya; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2018 |
In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Enterobacter; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sentinel Surveillance | 2018 |
Activity of imipenem/relebactam against Gram-negative bacilli from global ICU and non-ICU wards: SMART 2015-2016.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests | 2018 |
Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis.
Topics: Ertapenem; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella pneumoniae; Quinolones; Sepsis; Shock, Septic; Urinary Tract Infections | 2019 |
The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cefazolin; Ceftriaxone; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Vancomycin; Voriconazole; Young Adult | 2019 |
Antibacterial effect of imipenem/relebactam on aerobic Gram-negative bacilli: in vitro simulations of 7 or 14 day human exposures.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Computer Simulation; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Time Factors | 2019 |
Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Intestines; Male; Meropenem; Middle Aged; Propensity Score; Retrospective Studies | 2019 |
Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Breast Implantation; Breast Implants; Device Removal; Drainage; Drug Resistance, Bacterial; Female; Fluoroquinolones; Free Tissue Flaps; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Injections, Intravenous; Microbial Sensitivity Tests; Middle Aged; Radiography, Interventional; Reoperation; Retrospective Studies; Surgical Wound Infection; Tissue Expansion Devices; Treatment Outcome; Vancomycin | 2013 |
Rapid detection of blaVIM-1-37 and blaKPC1/2-12 alleles from clinical samples by multiplex PCR-based assays.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Sensitivity and Specificity; Thienamycins | 2013 |
Bacteremia due to imipenem-resistant Roseomonas mucosa in a child with acute lymphoblastic leukemia.
Topics: Anti-Bacterial Agents; Bacteremia; Child; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Methylobacteriaceae; Mucous Membrane; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis | 2014 |
[Infective endocarditis by Rhizobium radiobacter. A case report].
Topics: Agrobacterium tumefaciens; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Equipment Contamination; Gram-Negative Bacterial Infections; Humans; Imipenem; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Subclavian Vein; Tricuspid Valve Insufficiency; Vancomycin | 2013 |
Pharmacokinetics and pharmacodynamics of imipenem and meropenem in critically ill patients treated with continuous venovenous hemodialysis.
Topics: Anti-Bacterial Agents; Critical Illness; Drug Dosage Calculations; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Medication Errors; Meropenem; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Thienamycins | 2014 |
Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, General; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Singapore; Thienamycins; Young Adult | 2013 |
A comparative study of clinical Aeromonas dhakensis and Aeromonas hydrophila isolates in southern Taiwan: A. dhakensis is more predominant and virulent.
Topics: Adult; Aeromonas; Aged; Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Ceftriaxone; Cell Survival; DNA Gyrase; DNA-Directed RNA Polymerases; Female; Fibroblasts; Gentamicins; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Prevalence; Sequence Analysis, DNA; Soft Tissue Infections; Survival Analysis; Taiwan; Wound Infection | 2014 |
Comparison of test methods for detecting metallo-β-lactamase-producing Gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 2013 |
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Administration, Topical; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Colistin; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Imipenem; Injections, Intraperitoneal; Klebsiella pneumoniae; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2014 |
High-level and novel mechanisms of carbapenem resistance in Gram-negative bacteria from tertiary hospitals in Nigeria.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Conjugation, Genetic; Genotype; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Molecular Typing; Nigeria; Plasmids; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA; Tertiary Care Centers; Transformation, Bacterial | 2014 |
Use of imipenem to detect KPC, NDM, OXA, IMP, and VIM carbapenemase activity from gram-negative rods in 75 minutes using liquid chromatography-tandem mass spectrometry.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Chromatography, Liquid; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Sensitivity and Specificity; Tandem Mass Spectrometry | 2014 |
Molecular characteristics of carbapenem-resistant gram-negative bacteria in southern China.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Genes, Bacterial; Glutathione Transferase; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Integrons; Meropenem; Mutagenesis, Insertional; Thienamycins | 2015 |
Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Load; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Treatment Outcome | 2015 |
Evaluation of the Blue-Carba test for rapid detection of carbapenemases in gram-negative bacilli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests | 2015 |
Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011-2014.
Topics: Adolescent; Amikacin; Appendicitis; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Europe; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant; Male; Microbial Sensitivity Tests | 2017 |
Boronic acid disk diffusion for the phenotypic detection of polymerase chain reaction-confirmed, carbapenem-resistant, gram-negative bacilli isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Boronic Acids; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Phenotype; Polymerase Chain Reaction; Thienamycins | 2016 |
Clinical presentations, risk factors and outcomes of ceftazidime-resistant Gram-negative endophthalmitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Cephalosporin Resistance; Child; Child, Preschool; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Body | 2017 |
Universal protocol for the rapid automated detection of carbapenem-resistant Gram-negative bacilli directly from blood cultures by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS).
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacteremia; beta-Lactam Resistance; Blood Culture; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2016 |
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enoxacin; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Low Birth Weight; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Ofloxacin; Pakistan; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2016 |
Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing.
Topics: Achromobacter denitrificans; Aged; Aged, 80 and over; Anti-Bacterial Agents; Beijing; beta-Lactam Resistance; Catheters, Indwelling; Cross Infection; Female; Gram-Negative Bacterial Infections; Hospitals, General; Hospitals, Veterans; Humans; Imipenem; Male; Pneumonia, Bacterial; Retrospective Studies; Risk Factors | 2017 |
Imipenem-EDTA disk method for rapid identification of metallo-beta-lactamase producing Gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamases; Chelating Agents; Edetic Acid; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests | 2008 |
Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem.
Topics: beta-Lactamases; beta-Lactams; Drug Interactions; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Imipenem | 2008 |
Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Hybridization, Genetic; Imipenem; Integrons; Microbial Sensitivity Tests; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Taiwan | 2008 |
Development of imipenem resistance in an Aeromonas veronii biovar sobria clinical isolate recovered from a patient with cholangitis.
Topics: Aeromonas; Aged, 80 and over; Anti-Bacterial Agents; Cholangitis; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem | 2009 |
Epidemiology of antimicrobial resistance among gram-negative organisms recovered from patients in a multistate network of long-term care facilities.
Topics: Anti-Bacterial Agents; Ceftazidime; Colony Count, Microbial; Cross Infection; Cross-Sectional Studies; Delaware; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella; Long-Term Care; Microbial Sensitivity Tests; New Jersey; Pennsylvania; Prevalence; Proteus mirabilis; Skilled Nursing Facilities | 2009 |
[A community acquired pneumonia case caused by Ralstonia pickettii].
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Community-Acquired Infections; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Opportunistic Infections; Pneumonia, Bacterial; Protease Inhibitors; Pulmonary Disease, Chronic Obstructive; Ralstonia pickettii; Treatment Outcome | 2009 |
[Alcaligenes xylosoxidans bacteremia in a patient with acute lymphoblastic leukemia].
Topics: Alcaligenes; Anti-Bacterial Agents; Bacteremia; Child, Preschool; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2009 |
Characterization of regulatory element Rp3 of regulation of beta-lactamases from Ralstonia pickettii.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Cystic Fibrosis; DNA, Bacterial; Gene Expression Regulation, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Molecular Sequence Data; Promoter Regions, Genetic; Ralstonia pickettii; Transcription Factors; Transcription Initiation Site; Transcriptional Activation | 2009 |
[A case of ventilator-associated pneumonia caused by Cupriavidus pauculus].
Topics: Anti-Bacterial Agents; Breast Neoplasms; Cupriavidus; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Respiratory Insufficiency; Ventilators, Mechanical | 2010 |
The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department.
Topics: Acinetobacter; Anti-Infective Agents; Burn Units; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella pneumoniae; Ofloxacin; Pseudomonas aeruginosa | 2010 |
Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli.
Topics: Agar; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Culture Media; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Mass Screening; Microbial Sensitivity Tests | 2010 |
In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: results of the COMPACT Asia-Pacific Study.
Topics: Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pacific Islands; Thienamycins | 2010 |
[Ochrobactrum anthropi and polymicrobial peritonitis in peritoneal dialysis: a resistance predictor].
Topics: Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluconazole; Glomerulonephritis, IGA; Gram-Negative Bacterial Infections; Humans; Imipenem; Middle Aged; Ochrobactrum anthropi; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections | 2010 |
Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Korea; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Thienamycins; Urinary Tract Infections | 2011 |
Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program-Asia-Pacific Region.
Topics: Anti-Bacterial Agents; Asia; Australia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Injections, Intravenous; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Thienamycins | 2011 |
Comparative activity of carbapenem testing: the COMPACT study.
Topics: Africa; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle East; Thienamycins | 2011 |
Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Rectum; Stenotrophomonas maltophilia; Thienamycins | 2011 |
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey | 2011 |
Antimicrobial susceptibility patterns of clinical isolates of gram-negative bacteria obtained from intensive care units in a tertiary hospital in Beijing, China.
Topics: Amikacin; Anti-Bacterial Agents; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests | 2011 |
Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.
Topics: Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; South Africa | 2012 |
Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh.
Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Bangladesh; beta-Lactamases; Citrobacter freundii; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Female; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant; Klebsiella pneumoniae; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Plasmids; Prevalence; Prospective Studies; RNA, Ribosomal, 16S; Young Adult | 2012 |
Proteomic analysis of clinical isolate of Stenotrophomonas maltophilia with blaNDM-1, blaL1 and blaL2 β-lactamase genes under imipenem treatment.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gene Expression; Gene Expression Regulation, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Phenotype; Proteome; Proteomics; Stenotrophomonas maltophilia | 2012 |
Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region.
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pacific Islands; Thienamycins; Time Factors | 2013 |
Capnocytophaga canimorsus infection presenting with complete splenic infarction and thrombotic thrombocytopenic purpura: a case report.
Topics: Aged; Animals; Anti-Bacterial Agents; Bites and Stings; Capnocytophaga; Dogs; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Purpura, Thrombotic Thrombocytopenic; Splenic Infarction; Thienamycins | 2012 |
Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Colon; Enterobacteriaceae; Female; Gene Expression; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Stenotrophomonas maltophilia | 2013 |
Eikenella corrodens brain abscess after repeated periodontal manipulations cured with imipenem and neurosurgery.
Topics: Anti-Bacterial Agents; Brain Abscess; Drainage; Eikenella corrodens; Frontal Lobe; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Obsessive-Compulsive Disorder; Oral Hygiene | 2002 |
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Brazil; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Common Bile Duct; Disease Susceptibility; Female; Gallstones; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Patient Admission; Penicillins; Treatment Outcome | 2003 |
[Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)].
Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Argentina; Cephalosporins; Child; Ciprofloxacin; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Newborn; Intensive Care Units; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies | 2003 |
Imipenem levels are not predictable in the critically ill patient.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Area Under Curve; Blood Pressure; Chromatography, High Pressure Liquid; Critical Care; Female; Gram-Negative Bacterial Infections; Half-Life; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Prospective Studies; Wounds, Nonpenetrating | 2004 |
Asaia bogorensis peritonitis identified by 16S ribosomal RNA sequence analysis in a patient receiving peritoneal dialysis.
Topics: Acetobacteraceae; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Imipenem; Kidney Failure, Chronic; Peritoneal Dialysis; Peritonitis; Ribotyping; RNA, Bacterial; RNA, Ribosomal, 16S; Tobramycin | 2004 |
Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: a KONSAR study in 2002.
Topics: Anti-Bacterial Agents; Cefoxitin; Drug Resistance, Bacterial; Enterococcus; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Korea; Prevalence; Vancomycin Resistance | 2004 |
Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections.
Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infection Control; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Surgical Wound Infection; Turkey | 2005 |
Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Pediatric; Humans; Imipenem; Italy; Neoplasms; Retrospective Studies | 2005 |
Imipenem-resistant Achromobacter xylosoxidans carrying blaVIM-2-containing class 1 integron.
Topics: Achromobacter denitrificans; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Imipenem; Integrons; Korea; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2005 |
Sensitive EDTA-based microbiological assays for detection of metallo-{beta}-lactamases in nonfermentative gram-negative bacteria.
Topics: Bacteriological Techniques; beta-Lactamases; Edetic Acid; Escherichia coli; Evaluation Studies as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Reproducibility of Results; Sensitivity and Specificity | 2005 |
The postantibiotic effect (PAE) of the new penem FCE 22101 on gram-positive and -negative bacteria in vitro and in vivo.
Topics: Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests | 1989 |
Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fluoroquinolones; Gammaproteobacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Population Surveillance; Vancomycin; Vancomycin Resistance | 2006 |
Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia.
Topics: Aged; Bacteremia; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Polymerase Chain Reaction; Shewanella; Treatment Failure | 2006 |
Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Imipenem; Inpatients; Intensive Care Units; Length of Stay; Microbial Sensitivity Tests; Risk Factors | 2006 |
Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Topics: Aeromonas; Aged; Aged, 80 and over; Antineoplastic Agents; Bacteremia; Consciousness Disorders; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Hospitals; Humans; Imipenem; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Piperacillin; Prognosis; Risk Factors; Shock, Septic; Taiwan; Time Factors | 2006 |
Chromobacterium violaceum infection.
Topics: Adult; Anti-Bacterial Agents; Chromobacterium; Fatal Outcome; Gram-Negative Bacterial Infections; Humans; Imipenem; Liver Abscess, Pyogenic; Male; Pneumonia, Bacterial; Skin Diseases, Bacterial | 2006 |
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; beta-Lactams; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Proteins; Rats; Rats, Wistar; Shock, Septic | 2006 |
In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Enterobacteriaceae; Ertapenem; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella; Meropenem; Microbial Sensitivity Tests; Proteus; Sweden; Thienamycins | 2006 |
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey | 2007 |
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Probability; Retrospective Studies; Sensitivity and Specificity; Tazobactam; Treatment Outcome | 2007 |
[Sepsis caused by pigmented and no pigmented Chromobacterium violaceum].
Topics: Amikacin; Anti-Bacterial Agents; Chromobacterium; Fatal Outcome; Gram-Negative Bacterial Infections; Humans; Imipenem; Indians, South American; Infant; Male; Psoas Abscess; Sepsis | 2007 |
[Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2007 |
Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Ceftazidime; Cell Wall; Escherichia coli Infections; Female; Galactosamine; Gram-Negative Bacterial Infections; Imipenem; Lipopolysaccharides; Mice; Mice, Inbred C3H; Sepsis | 1995 |
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
Topics: beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; International Cooperation; Microbial Sensitivity Tests | 1994 |
In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients.
Topics: Anti-Bacterial Agents; Azlocillin; Clavulanic Acid; Clavulanic Acids; Drug Evaluation; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Neutropenia; Piperacillin; Pseudomonas aeruginosa; Sepsis; Ticarcillin | 1994 |
In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Thienamycins | 1993 |
Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Indicators and Reagents; Microbial Sensitivity Tests | 1993 |
Ochrobactrum anthropi bacteremia in a child.
Topics: Bacteremia; Ceftazidime; Child; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin | 1993 |
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacter; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Hospital Bed Capacity; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Lung; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Pseudomonas aeruginosa; Risk Factors; Thienamycins; Wounds and Injuries | 1996 |
Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.
Topics: Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1997 |
Fatal myofascial necrosis due to imipenem-resistant Aeromonas hydrophila.
Topics: Adult; Aeromonas hydrophila; Amikacin; Anemia, Aplastic; Anti-Bacterial Agents; Drug Resistance, Microbial; Fatal Outcome; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Male; Muscular Diseases; Necrosis; Thienamycins; Thigh | 1997 |
Secular trends in bloodstream infection caused by antimicrobial-resistant bacteria in New Jersey hospitals, 1991 to 1995.
Topics: Bacteremia; Cross Infection; Data Collection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Private; Humans; Imipenem; Microbial Sensitivity Tests; New Jersey; Penicillin Resistance; Pneumococcal Infections; Prevalence; Species Specificity; Streptococcus pneumoniae; Vancomycin | 1997 |
Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains.
Topics: Aeromonas; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pakistan; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Utility of serial rectal swab cultures for detection of ceftazidime- and imipenem-resistant gram-negative bacilli from patients in the intensive care unit.
Topics: Adult; Aged; beta-Lactam Resistance; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rectum; Thienamycins | 1998 |
Aeromonas sobria infection with severe soft tissue damage and segmental necrotizing gastroenteritis in a patient with alcoholic liver cirrhosis.
Topics: Aeromonas; Dopamine; Enterocolitis, Necrotizing; Fatal Outcome; Gastroenteritis; Gram-Negative Bacterial Infections; Humans; Imipenem; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Minocycline; Multiple Organ Failure; Norepinephrine; Shock, Septic; Soft Tissue Infections | 1999 |
In-vitro disk diffusion sensitivity of meropenem against bacterial pathogens in Harare.
Topics: Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Longitudinal Studies; Meropenem; Microbial Sensitivity Tests; Thienamycins; Zimbabwe | 1999 |
Prevalent nosocomial gram negative aerobic bacilli and their antimicrobial susceptibility pattern in intensive care unit.
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Newborn; Intensive Care Units; Microbial Sensitivity Tests; Prospective Studies; Thienamycins | 1999 |
Purulent pericarditis presenting as an extracardiac mass in a patient with untreated diabetes.
Topics: Anti-Infective Agents, Local; Cardiac Catheterization; Cardiac Output, Low; Diabetes Complications; Diagnosis, Differential; Empyema, Pleural; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Pericarditis, Constrictive; Pleural Effusion; Povidone-Iodine; Suppuration; Thienamycins; Tissue Adhesions; Tomography, X-Ray Computed | 1999 |
[Clinical of 50 cases of aged patients with pneumonia caused by gram-negative bacteria].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Kanamycin; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Thienamycins | 1998 |
Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Utilization; Forecasting; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Time Factors | 2000 |
Incidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Anti-Bacterial Agents; Bacteroidaceae Infections; beta-Lactam Resistance; beta-Lactamases; Cefmetazole; Cephalosporin Resistance; Cephamycins; Chi-Square Distribution; Clindamycin; Erythromycin; Fusobacterium; Gram-Negative Anaerobic Straight, Curved, and Helical Rods; Gram-Negative Bacterial Infections; Humans; Imipenem; Metronidazole; Middle Aged; Minocycline; Periodontal Diseases; Porphyromonas; Prevotella; Sulbactam; Thienamycins; Tooth Diseases | 2001 |
Discordant carbapenem susceptibility in Methylobacterium species and its application as a method for phenotypic identification.
Topics: Carbapenems; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Methylobacterium; Microbial Sensitivity Tests; Phenotype; Thienamycins | 2001 |
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Statistics as Topic; Sulbactam | 2001 |
Surveillance for antimicrobial resistance in Croatia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Croatia; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Imipenem; Klebsiella pneumoniae; Methicillin Resistance; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Public Health; Staphylococcus aureus; Streptococcus pneumoniae | 2002 |
[The effect of antibiotic therapy on lung pathology in experimental models of sepsis].
Topics: Animals; Bacteroides fragilis; Disease Models, Animal; Escherichia coli; Gram-Negative Bacterial Infections; Imipenem; Lung Diseases; Prognosis; Rats; Rats, Wistar; Sepsis; Thienamycins | 2002 |
[Sensitivity of multiresistant bacterial strains to imipenem (Tienam)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Microbial Sensitivity Tests | 1992 |
Response of Weeksella virosa peritonitis to imipenem/cilastin.
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
Imipenem/cilastatin drug utilization evaluation in a large community hospital.
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Utilization; Evaluation Studies as Topic; Female; Gram-Negative Bacterial Infections; Hospitals, Community; Humans; Imipenem; Male; Middle Aged | 1991 |